Navigation Links
Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date
Date:2/29/2008

LINTHICUM, Md., Feb. 29 /PRNewswire-FirstCall/ -- Dialysis Corporation of America (Nasdaq: DCAI) announced today that it will release its 2007 fourth quarter and full year financial results on March 13, 2008, after the close of the market. The company will also begin hosting conference calls in conjunction with its quarterly earnings releases, beginning with this quarter. The conference call will he held the following morning, March 14, 2008 at 10:00 AM EDT.

Those interested may dial in at 800-750-4984 using passcode 5178437, or through simulcast on the internet at http://www.vcall.com/IC/CEPage.asp?ID=126643. The call will be available for replay on the company's website for the following thirty days.

Separately, the company announced the appointment of Andrew Jeanneret as the company's Chief Financial Officer, effective with the filing of the 2007 10K. Mr. Jeanneret, who has been serving the company as Vice President of Finance since August of 2007, will be replacing Dan Ouzts, who has been serving as the interim CFO since late 2005. Mr. Ouzts will continue to provide financial, treasury, and SEC guidance for DCA, through the DCA regional offices in Florida.

Stephen Everett, President and Chief Executive Officer commented, "The combined finance team of Andrew and Dan will provide our company with a higher level of financial insight into the growth and strategic plans for DCA. I look forward to working with Andrew in his new role and the continued relationship that has been enjoyed with Dan over the years."

This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, maintaining continued growth and profitability, delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's dialysis facilities can mature to provide profitability, the extensive regulation of dialysis operations, government rate determination for Medicare reimbursement, pricing pressure from private payors, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2006. The historical results contained in this press release are not necessarily indicative of future performance of the company.

The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.


'/>"/>
SOURCE Dialysis Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dialysis Corporation of America Announces its Newest Center Opening in South Carolina
2. Standard test for blood sugar control not accurate in diabetic dialysis patients
3. Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio
4. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
5. 16-Year-Old Ecuadorian Boy in Dire Need of Dialysis Treatments Thanks One of Nations Leading Providers for Saving His Life
6. Study questions impact of hemoglobin variations on mortality in dialysis patients
7. New anemia measure predicts risk of death in dialysis patients
8. Home Dialysis Clinical Research Study is Underway - Focuses on At-Home Extended Duration Treatment
9. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
10. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
11. Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx ... dynamic expert and thoughtful presentation to give attendees a better sense of how to ... free to attend, but registration is required. , Rehabilitation of Offensive Lineman ...
(Date:2/10/2016)... Glendale, CA (PRWEB) , ... February 10, 2016 , ... ... can be harder to find. Unfortunately, this can leave patients with dental emergencies at ... Glendale , is now offering emergency dental care. , Common dental emergencies include:, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 ... more than 200 of the country’s top healthcare executives to share insights on ... benefit of the Forum is the provider-centric perspective, experience, expertise and strategy shared ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined ... readily available to physicians. The integration will enable Allscripts users to post open ... Everseat’s free mobile app. , The partnership gives Everseat substantial added power to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... new market research report "Pharmaceutical Packaging Equipment Market by ... Labeling & Serialization), by Product Type (Tablet, Powder, Cream, ... published by MarketsandMarkets, studies the global market during the forecast ... to grow at a CAGR of 6.9% during the ...
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/10/2016)... , February 10, 2016 ... Medicine, Targeted Therapeutics and Companion Diagnostic Market to ... Participants, and Environment" research report indicates that the ... $149 billion by 2020 growing at a CAGR ... companion diagnostics and targeted therapeutics and is dominated ...
Breaking Medicine Technology: